Investigative Ophthalmology & Visual Science Cover Image for Volume 65, Issue 7
June 2024
Volume 65, Issue 7
Open Access
ARVO Annual Meeting Abstract  |   June 2024
Clusterin modulates trabecular meshwork actin dynamics and extracellular matrix through Tensins
Author Affiliations & Notes
  • Anusha Shivashankar
    Indiana University Department of Ophthalmology, Indianapolis, Indiana, United States
  • Avinash Soundararajan
    Indiana University Department of Ophthalmology, Indianapolis, Indiana, United States
  • Padmanabhan P Pattabiraman
    Indiana University Department of Ophthalmology, Indianapolis, Indiana, United States
    Stark Neurosciences Research Institute, Indianapolis, Indiana, United States
  • Footnotes
    Commercial Relationships   Anusha Shivashankar None; Avinash Soundararajan None; Padmanabhan Pattabiraman None
  • Footnotes
    Support  NIH/NEI -R01EY029320, Ralph W. and Grace M. Showalter Research Trust andthe Indiana University School of Medicine, Research Support Funds Grant (RSFG), Cohen AMD ResearchPilot Grant, Grant from Research to Prevent Blindness to IU
Investigative Ophthalmology & Visual Science June 2024, Vol.65, 5150. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Anusha Shivashankar, Avinash Soundararajan, Padmanabhan P Pattabiraman; Clusterin modulates trabecular meshwork actin dynamics and extracellular matrix through Tensins. Invest. Ophthalmol. Vis. Sci. 2024;65(7):5150.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : In our previous study, we demonstrated that the clusterin knockout mice showed increased intraocular pressure (IOP) as a result of enhanced actin polymerization. We aimed to elucidate the impact of clusterin gain-of-function on the actin cytoskeletal dynamics in human TM (HTM) cells.

Methods : We performed-A) tandem mass spectrometry-based global proteomic analysis on HTM cells constitutively expressing clusterin (AdCLU) compared to control (AdMT). Screening criteria for protein level changes included p≤0.05 and mean±2σ of log2≥0.2 as the confidence fold change (FC). B) Label-free proteomic analysis of co-immunoprecipitated (Co-IP) samples with tensin 3 (TNS3) antibody to determine its interactors. C) Immunofluorescence (IF) to determine - the distribution of TNS3 in the human ocular hypertensive (OHT) outflow pathway, the effect of siRNA-mediated loss of TNS3 (siTNS3), and the effect of pcDNA-EGFP-TNS3 (eTNS3)-mediated overexpression on actin fibers. D) Immunoblotting (IB) to analyze the effect of the siTNS3 on actin-associated proteins. Statistical analyses were performed using a student’s t-test with significance at p≤0.05 (n=4).

Results : Proteomic analysis showed AdCLU reduced actin alpha 1 (p=0.046, log2FC=-0.5), TNS1 (p= 0.08, log2FC=-0.23), TNS3 (p=0.02, log2FC=-0.44), and TNS4 (p=0.04, log2FC=-0.220) levels. Confirmatory analysis by IB showed that AdCLU significantly reduced TNS3 (p=0.01). IF demonstrated higher TNS3 expression in the TM outflow pathway of the OHT tissues compared to normotensive tissues. Proteomics of Co-IP samples using TNS3 antibody revealed interactions with major cytoskeletal and extracellular matrix proteins, including vimentin, actins- actin gamma 1, actin alpha cardiac muscle 1, filamin-A, twinfilin-2, and tenascin-c. siTNS3 reduced F-actin distribution compared to siScrambled (siScr). Further, IB analysis showed a significant downregulation of fibronectin (p=0.04) and vimentin (p=0.03) in siTNS3 compared to siScr. Additionally, IF demonstrated that induction of TNS3 using eTNS3 expression plasmid induced F-actin and increased the distribution of active integrin β1 and β3 compared to control.

Conclusions : This novel study presents the firsthand report on how clusterin regulates actin and integrin adhesome complex regulators like the tensins that can modify fibrillogenesis via integrins, defining players in effecting TM biomechanics and IOP.

This abstract was presented at the 2024 ARVO Annual Meeting, held in Seattle, WA, May 5-9, 2024.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×